查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
下一代測序樣本庫製備自動化市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測，按產品、測序類型、按應用、最終用戶、公司和地區細分
市場調查報告書
商品編碼
1321046

下一代測序樣本庫製備自動化市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測，按產品、測序類型、按應用、最終用戶、公司和地區細分

Next Generation Sequencing Library Preparation Automation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product, By Sequencing Type, By Application, By End User, By Company and By Region
出版日期: | 出版商: TechSci Research | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

預計全球下一代測序 (NGS) 樣本庫製備自動化市場在2023年至2027年預測期內將出現令人印象深刻的成長。主要因素包括各種疾病發病率的增加、對下一代測序的需求不斷增加以及政府舉措的增加，這些都抑制了市場的成長。下一代測序（NGS）是一種並行處理技術，能夠以超高容量、可擴展性和高速建立全基因組中的核苷酸序列。新一代測序（NGS）包括樣本預處理、樣本庫製備、測序和生物資訊學等步驟。樣本庫製備過程在 NGS 工作流程中非常重要，但由於需要高精度移液的多個重複步驟，因此非常耗時。樣本庫製備的自動化可以提高效率、產生更穩定的結果並提高實驗室效率。支持市場成長的其他因素包括廣泛的研究和開發、大量的臨床試驗、意識的提高、各種政府投資、公司之間越來越多的合作建立樣本庫製備方案以及技術進步。

對下一代測序的需求不斷成長

下一代測序 (NGS) 是一種使用 DNA 和 RNA 測序以及突變檢測的技術。它可以在更短的時間內對數千個基因或基因組進行測序，這大幅增加了對其使用的需求。 NGS 需求的不斷成長推動市場的成長。這歸因於個性化醫療、農業研究、藥物發現、基因組學、癌症和動物研究等廣泛的應用。它還用於非編碼 RNA、轉錄因子結合位點的識別以及重新測序。由於其準確、高效、先進的系統以及低成本，NGS 需求的成長推動市場的成長。例如，2018年，醫療保險和醫療補助服務中心 (CMS) 宣布全國覆蓋範圍決定開展 NSG 測試來診斷癌症。此外，新一代測序在食品安全和品質方面的使用推動市場的成長。

增加投資和研發活動

政府和主要市場參與者投資於各種研發活動，促進了市場的成長。2022年，美國國立衛生研究院生物技術融資總額為79,120億美元。製藥和生物技術公司主要致力於研發（R&D），這是藥物開發過程的核心部分。由於藥品批准數量不斷增加，研發的重要性顯而易見。例如，2020年 FDA 藥物評價與研究中心 (CDER) 認證了 53 種新藥，而2019年批准了 48 種新藥。在美國，到2019年底，科學研發收入可能達到 81.1 億美元。2022年。此外，各國政府加強NGS在研發中使用的舉措的增加以及技術的持續創新和進步推動市場的成長。例如，2018年，澳洲政府宣佈在未來 10年內投資 3.72 億美元，用於基因組健康未來任務，對20 萬名參賽者進行測序。

市場細分

全球下一代測序（NGS）樣本庫製備自動化市場按產品、測序類型、應用、最終用戶和公司細分。根據產品，市場分為套件和消耗品以及儀器。根據測序類型，市場分為DNA測序和RNA測序。根據應用，市場分為診斷和科學研究。根據最終用戶，市場分為製藥和生物技術公司、臨床和診斷實驗室、學術和研究機構等。就國家而言，由於美國遺傳性疾病發生率的增加和技術的廣泛發展，預計在預測期內美國將成為一個利潤豐厚的市場。

市場參與者

Agilent Technologies, Inc.、BGI Group、Aurora Biomed Inc.、Bio-Rad Laboratories, Inc.、Danaher Corporation、F.Hoffmann-La Roche AG、Eppendorf SE、Hamilton Company、Hologic Inc.、Illumina Inc.、Oxford Nanopore Technologies Limited、PerkinElmer, Inc.、Promega Corporation、Takara Bio Inc. 和QIAGEN NV 是市場上營運的一些領先公司。

可用的客製化

根據給定的市場資料，TechSci Research 可根據公司的具體需求提供客製化服務。本報告可以使用以下自定義選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：COVID-19 對全球下一代測序 (NGS) 樣本庫製備自動化市場的影響

第5章：客戶之聲

第6章：全球下一代測序 (NGS) 樣本庫製備自動化市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品（套件和消耗品與儀器）
    • 按測序類型（DNA 測序 vs RNA 測序）
    • 按應用（診斷與科學研究）
    • 按最終用戶（製藥和生物技術公司、臨床和診斷實驗室、學術和研究機構、其他）
    • 按公司分類 (2021)
    • 按地區
  • 市場地圖

第7章：北美下一代測序 (NGS) 樣本庫製備自動化市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品分類
    • 按測序類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第8章：歐洲下一代測序 (NGS) 樣本庫製備自動化市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品分類
    • 按測序類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第9章：亞太地區下一代測序 (NGS) 樣本庫製備自動化市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品分類
    • 按測序類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第10章：南美洲下一代測序 (NGS) 樣本庫製備自動化市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品分類
    • 按測序類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章：中東和非洲下一代測序 (NGS) 樣本庫製備自動化市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品分類
    • 按測序類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非下一代測序 (NGS) 樣本庫製備自動化
    • 沙烏地阿拉伯下一代測序 (NGS) 樣本庫製備自動化
    • 阿拉伯聯合大公國下一代測序 (NGS) 樣本庫製備自動化
    • 土耳其下一代測序 (NGS) 樣本庫製備自動化
    • 埃及 下一代測序 (NGS) 樣本庫製備自動化

第12章：市場動態

  • 促進因素
  • 挑戰

第13章：市場趨勢與發展

第14章：競爭格局

  • Agilent Technologies, Inc.
  • BGI Group
  • Aurora Biomed Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F.Hoffmann-La Roche AG
  • Eppendorf SE
  • Hamilton Company
  • Hologic Inc.
  • Illumina Inc.
  • Oxford Nanopore Technologies Limited
  • PerkinElmer, Inc.
  • Promega Corporation
  • Takara Bio Inc.
  • QIAGEN NV

第15章：戰略建議

簡介目錄
Product Code: 13010

The global next-generation sequencing (NGS) library preparation automation market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include growing incidences of various diseases, rising demand for next-generation sequencing, and a rise in government initiatives, which are curbing the market's growth. Next-generation Sequencing (NGS) is a parallel processing technology that can establish the sequence of nucleotides in a whole genome with ultra-high capacity, scalability, and high speed. Next-generation sequencing (NGS) includes steps such as sample pre-processing, library preparation, sequencing, and bioinformatics. The library preparation process is crucial in NGS workflow but is very time-consuming due to the several repetitive steps requiring small volumes to be pipetted with high accuracy. The automation of library preparation can enhance efficiency, produce more steady results, and improve lab efficacy. The other factors supporting the market's growth are the extensive research and development, the large number of clinical trials, increasing awareness, various government investments, the growing number of collaborations between companies to build library preparation protocols, and technological advancements.

Rising demand for Next Generation Sequencing

Next-generation sequencing (NGS) is a technique that uses DNA and RNA sequencing and mutation detection. It sequences thousands of genes or genomes in a shorter time, which surges the demand for its usage. Growing demand for NGS is fueling the growth of the market. This is attributed to the wide range of applications such as personalized medicines, agricultural research, drug discovery, genomics, cancer, and animal research. It is also used for non-coding RNA, identification of binding sites on transcriptional factors, and resequencing. Owing to its accurate, efficient, and advanced system, along with low costs, the rise in demand for NGS is bolstering the growth of the market. For instance, in 2018, the Centers for Medicare & Medicaid Services (CMS) stated the National Coverage Determination to carry out NSG tests to diagnose cancer. In addition, the use of next-generation sequencing in food safety and quality is propelling the market's growth.

Increasing Investments and R&D Activities

Governments and key market players invest in various R&D activities, which augments the market's growth. In 2022, total biotechnology financing by the National Institutes for Health was USD 7,912 billion. Pharmaceutical and biotechnology companies majorly focus on research and development (R&D), a core part of drug development processes. The significance of R&D is noticeable due to the growing number of drug approvals. For instance, in 2020, the FDA's Center for Drug Evaluation and Research (CDER) certified 53 novel drugs, whereas 48 were approved in 2019. In the U.S., the revenue in scientific R&D is likely to amount to USD 8.11 billion by the end of 2022. Also, the rise in initiatives by governments to enhance the use of NGS in R&D and continuous innovation and advancements in technology are driving the growth of the market. For instance, in 2018, the Australian government declared an investment of $372 million for over 10 years in its Genomics Health Futures Mission to sequence 200,000 contestants.

Market Segmentation

The global next-generation sequencing (NGS) library preparation automation market is segmented into product, sequencing type, application, end-user, and company. Based on product, the market is divided into kits and consumables, and instruments. Based on sequencing type, the market is divided into DNA sequencing and RNA sequencing. Based on application, the market is segmented into diagnostics and scientific research. Based on end users, the market is divided into pharmaceutical & biotechnology companies, clinical & diagnostic laboratories, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to an increase in occurrences of genetic diseases and extensive technology development in the country.

Market Players

Agilent Technologies, Inc., BGI Group, Aurora Biomed Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F.Hoffmann-La Roche AG, Eppendorf SE, Hamilton Company, Hologic Inc., Illumina Inc., Oxford Nanopore Technologies Limited, PerkinElmer, Inc., Promega Corporation, Takara Bio Inc., and QIAGEN NV are some of the leading companies operating in the market.

Report Scope

In this report, the global next generation sequencing (NGS) library preparation automation market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Next Generation Sequencing (NGS) Library Preparation Automation Market, By Product:

  • Kits and Consumables
  • Instruments

Next Generation Sequencing (NGS) Library Preparation Automation Market, By Sequencing Type:

  • DNA Sequencing
  • RNA Sequencing

Next Generation Sequencing (NGS) Library Preparation Automation Market, By Application:

  • Diagnostics
  • Scientific Research

Next Generation Sequencing (NGS) Library Preparation Automation Market, By End User:

  • Pharmaceutical & Biotechnology Companies
  • Clinical & Diagnostic Laboratories
  • Academic & Research Institutions
  • Others

Next Generation Sequencing (NGS) Library Preparation Automation Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global next-generation sequencing (NGS) library preparation automation Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Next Generation Sequencing (NGS) Library Preparation Automation Market

5. Voice of Customer

6. Global Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Kits and Consumables v/s Instruments)
    • 6.2.2. By Sequencing Type (DNA Sequencing v/s RNA Sequencing)
    • 6.2.3. By Application (Diagnostics v/s Scientific Research)
    • 6.2.4. By End User (Pharmaceutical & Biotechnology Companies, Clinical & Diagnostic Laboratories, Academic & Research Institutions, Others)
    • 6.2.5. By Company (2021)
    • 6.2.6. By Region
  • 6.3. Market Map

7. North America Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Sequencing Type
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Sequencing Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Canada Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Sequencing Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Mexico Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Sequencing Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User

8. Europe Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Sequencing Type
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Sequencing Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Sequencing Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Sequencing Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Sequencing Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Sequencing Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Asia-Pacific Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Sequencing Type
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Sequencing Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. India Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Sequencing Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Japan Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Sequencing Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User
    • 9.3.4. South Korea Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product
        • 9.3.4.2.2. By Sequencing Type
        • 9.3.4.2.3. By Application
        • 9.3.4.2.4. By End User
    • 9.3.5. Australia Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product
        • 9.3.5.2.2. By Sequencing Type
        • 9.3.5.2.3. By Application
        • 9.3.5.2.4. By End User

10. South America Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Sequencing Type
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Sequencing Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Sequencing Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Sequencing Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Middle East and Africa Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Sequencing Type
    • 11.2.3. By Application
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Sequencing Type
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Sequencing Type
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Sequencing Type
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By End User
    • 11.3.4. Turkey Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Product
        • 11.3.4.2.2. By Sequencing Type
        • 11.3.4.2.3. By Application
        • 11.3.4.2.4. By End User
    • 11.3.5. Egypt Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Product
        • 11.3.5.2.2. By Sequencing Type
        • 11.3.5.2.3. By Application
        • 11.3.5.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Agilent Technologies, Inc.
  • 14.2. BGI Group
  • 14.3. Aurora Biomed Inc.
  • 14.4. Bio-Rad Laboratories, Inc.
  • 14.5. Danaher Corporation
  • 14.6. F.Hoffmann-La Roche AG
  • 14.7. Eppendorf SE
  • 14.8. Hamilton Company
  • 14.9. Hologic Inc.
  • 14.10. Illumina Inc.
  • 14.11. Oxford Nanopore Technologies Limited
  • 14.12. PerkinElmer, Inc.
  • 14.13. Promega Corporation
  • 14.14. Takara Bio Inc.
  • 14.15. QIAGEN NV

15. Strategic Recommendations